AU2154801A - Method for linking molecular substances - Google Patents

Method for linking molecular substances

Info

Publication number
AU2154801A
AU2154801A AU21548/01A AU2154801A AU2154801A AU 2154801 A AU2154801 A AU 2154801A AU 21548/01 A AU21548/01 A AU 21548/01A AU 2154801 A AU2154801 A AU 2154801A AU 2154801 A AU2154801 A AU 2154801A
Authority
AU
Australia
Prior art keywords
molecular substances
linking molecular
linking
proline
affinity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU21548/01A
Other languages
English (en)
Inventor
Gerald Bohm
Constanze Gunther
Christoph Parthier
Ulrich Schmidt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ACGT Progenomics AG
Original Assignee
ACGT Progenomics AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ACGT Progenomics AG filed Critical ACGT Progenomics AG
Publication of AU2154801A publication Critical patent/AU2154801A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1075—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of amino acids or peptide residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/22011—Polyomaviridae, e.g. polyoma, SV40, JC
    • C12N2710/22022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Peptides Or Proteins (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU21548/01A 1999-11-03 2000-11-03 Method for linking molecular substances Abandoned AU2154801A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19952956A DE19952956A1 (de) 1999-11-03 1999-11-03 Verfahren zur Verbindung von molekularen Substanzen
DE19952956 1999-11-03
PCT/EP2000/010873 WO2001032684A2 (de) 1999-11-03 2000-11-03 Verfahren zur verbindung von molekularen substanzen basierend auf der affinität der prolinreichen aminosäure-sequenzen und proteindomänem vom typ ww

Publications (1)

Publication Number Publication Date
AU2154801A true AU2154801A (en) 2001-05-14

Family

ID=7927813

Family Applications (1)

Application Number Title Priority Date Filing Date
AU21548/01A Abandoned AU2154801A (en) 1999-11-03 2000-11-03 Method for linking molecular substances

Country Status (8)

Country Link
US (1) US7807782B2 (https=)
EP (1) EP1227848B1 (https=)
JP (1) JP4112859B2 (https=)
CN (1) CN100357314C (https=)
AT (1) ATE326984T1 (https=)
AU (1) AU2154801A (https=)
DE (2) DE19952956A1 (https=)
WO (1) WO2001032684A2 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4885476B2 (ja) * 2004-05-21 2012-02-29 株式会社日本触媒 タンパク質及び／又はペプチドの細胞内導入方法
CA2697032C (en) 2007-08-22 2021-09-14 The Regents Of The University Of California Activatable binding polypeptides and methods of identification and use thereof
US20100189651A1 (en) * 2009-01-12 2010-07-29 Cytomx Therapeutics, Llc Modified antibody compositions, methods of making and using thereof
JP5861223B2 (ja) * 2009-02-23 2016-02-16 サイトムエックス セラピューティクス, インク.CytomX Therapeutics, Inc. プロタンパク質およびその使用方法
JP6236948B2 (ja) * 2013-07-17 2017-11-29 東ソー株式会社 抗体精製用溶出液および当該溶出液を用いた抗体精製方法
GB201409558D0 (en) 2014-05-29 2014-07-16 Ucb Biopharma Sprl Method
GB201412659D0 (en) 2014-07-16 2014-08-27 Ucb Biopharma Sprl Molecules
GB201412658D0 (en) 2014-07-16 2014-08-27 Ucb Biopharma Sprl Molecules
GB201601073D0 (en) 2016-01-20 2016-03-02 Ucb Biopharma Sprl Antibodies
GB201601075D0 (en) 2016-01-20 2016-03-02 Ucb Biopharma Sprl Antibodies molecules
GB201601077D0 (en) 2016-01-20 2016-03-02 Ucb Biopharma Sprl Antibody molecule
GB201521391D0 (en) 2015-12-03 2016-01-20 Ucb Biopharma Sprl Antibodies
GB201521383D0 (en) 2015-12-03 2016-01-20 Ucb Biopharma Sprl And Ucb Celltech Method
GB201521389D0 (en) 2015-12-03 2016-01-20 Ucb Biopharma Sprl Method
GB201521382D0 (en) 2015-12-03 2016-01-20 Ucb Biopharma Sprl Antibodies
GB201521393D0 (en) 2015-12-03 2016-01-20 Ucb Biopharma Sprl Antibodies
US11202841B2 (en) * 2018-08-20 2021-12-21 The Trustees Of Indiana University Virus-enabled targeted vector for imaging
CN111979206B (zh) * 2019-05-24 2021-08-17 深圳瑞德林生物技术有限公司 固定化融合酶及用其制备谷胱甘肽的方法
CN117642413A (zh) * 2021-08-31 2024-03-01 富士胶片株式会社 化合物及使用了该化合物的标记生物物质
CN115951051B (zh) * 2022-10-18 2024-01-12 北京卓诚惠生生物科技股份有限公司 一种高灵敏度新型冠状病毒抗原胶体金检测试剂盒及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6072039A (en) 1991-04-19 2000-06-06 Rohm And Haas Company Hybrid polypeptide comparing a biotinylated avidin binding polypeptide fused to a polypeptide of interest
US6503703B1 (en) * 1995-05-19 2003-01-07 Mount Sinai School Of Medicine Of New York University Identification and use of antiviral compounds that inhibit interaction of host cell proteins and viral proteins required for viral replication
US6007544A (en) * 1996-06-14 1999-12-28 Beth Israel Deaconess Medical Center Catheter apparatus having an improved shape-memory alloy cuff and inflatable on-demand balloon for creating a bypass graft in-vivo
US7666221B2 (en) * 2000-05-01 2010-02-23 Endovascular Technologies, Inc. Lock modular graft component junctions
US7044962B2 (en) * 2002-06-25 2006-05-16 Scimed Life Systems, Inc. Implantable prosthesis with displaceable skirt

Also Published As

Publication number Publication date
CN100357314C (zh) 2007-12-26
WO2001032684A2 (de) 2001-05-10
DE50012831D1 (de) 2006-06-29
JP4112859B2 (ja) 2008-07-02
DE19952956A1 (de) 2001-05-17
EP1227848B1 (de) 2006-05-24
US20060252130A1 (en) 2006-11-09
US7807782B2 (en) 2010-10-05
ATE326984T1 (de) 2006-06-15
CN1390140A (zh) 2003-01-08
WO2001032684A3 (de) 2002-04-18
EP1227848A2 (de) 2002-08-07
JP2003517300A (ja) 2003-05-27

Similar Documents

Publication Publication Date Title
AU2154801A (en) Method for linking molecular substances
WO2004092199A3 (en) Method for identifying modulators of g protein coupled receptor signaling
ZA988392B (en) Tie ligand homologues.
CY1110982T1 (el) Συνθεσεις και μεθοδοι για την αυξηση της ασβεστοποιησεως των οστων
ATE310090T1 (de) Gereinigte coprinus laccasen und nukleinsäuren welche dafür kodieren
AU2002217010A1 (en) Peptides, the production and use thereof for binding immunoglobulins
DE69434614D1 (de) Cdn apoptosis modulierende proteine, sie kodierende dns und verfahren zu ihrer verwendung
WO2001036676A3 (en) Security system
EP0892048A3 (en) XAF genes and polypeptides and their use for modulating apoptosis
AU2001238212A1 (en) Modified fluorescent proteins
MXPA01008605A (es) Proteina de enlace del antigeno goodpasture.
MX9806041A (es) Proteina purificada sr-p70.
WO2002066678A3 (en) Security system
AUPP627498A0 (en) Novel peptides - i
AU3711597A (en) A novel galanin receptor
EP0816498A3 (en) Excitatory amino acid receptor protein and related nucleic acid compounds
WO2002046378A3 (en) Alternative pol k nucleotide and amino acid sequence and methods for using
WO2003004678A3 (en) Novel receptors
WO2001092468A3 (en) Novel compositions for the expression of the human peptide histidine transporter 1 and methods of use thereof
AU2001276629A1 (en) Modulation of tetraspanin function
EP0950711A3 (en) Gonadotropin receptor
BR9914090A (pt) ácidos nucléicos codificando uma sub-unidade gama da proteìna g envolvida em transdução sensorial
WO2002038765A3 (en) Dna encoding bovine immunoglobulin a inducing protein and uses therefor
IL142664A0 (en) Prv-1 gene, processes for detecting the prv-1 polypeptide and pharmaceutical compositions containing the same
IL139272A0 (en) New peptide fragments for protein purification

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
TH Corrigenda

Free format text: IN VOL 15, NO 35, PAGE(S) 7527-7530 UNDER THE HEADING APPLICATIONS LAPSED, REFUSED OR WITHDRAWN PLEASE DELETE ALL REFERENCE TO APPLICATION NO. 17007/00, 64588/00, 79240/00, 79404/00, 79413/00, 10275/01, 10285/01, 10459/01, 10468/01, 11547/01, 11577/01, 11581/01, 11588/01, 11595/01, 11596/01, 11602/01, 11608/01, 11626/01, 11640/01, 11646/01, 11651/01, 11671/01, 11672/01, 11765/01, 12861/01, 12867/01, 12869/01, 12877/01, 12941/01, 13883/01, 13929/01, 14003/01, 14004/01, 14018/01, 14084/01, 14094/01, 15179/01, 15184/01, 15423/01, 15602/01, 16984/01, 17032/01, 17404/01, 17406/01, 17407/01, 17414/01, 18215/01, 18225/01, 19941/01, 19951/01, 19982/01, 21486/01, 21498/01, 21548/01, 21557/01, 2155

MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase